Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion.
Teirstein PS, Mann JT 3rd, Cundey PE Jr, Schechter E, Jacobs WC, Grines CL, Stagaman DJ, Lansky AJ, Hultquist MA, Kusnick BA, Heuser RR, Kleinert HD, Popma J.
Teirstein PS, et al. Among authors: lansky aj.
Am J Cardiol. 1999 Jun 15;83(12):1623-8. doi: 10.1016/s0002-9149(99)00163-0.
Am J Cardiol. 1999.
PMID: 10392865
Clinical Trial.